Advances in Human Genetics 1989
DOI: 10.1007/978-1-4613-0785-3_5
|View full text |Cite
|
Sign up to set email alerts
|

Genetics of Growth Hormone and Its Disorders

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
3
1
2

Year Published

1993
1993
2009
2009

Publication Types

Select...
4
2

Relationship

0
6

Authors

Journals

citations
Cited by 11 publications
(6 citation statements)
references
References 170 publications
0
3
1
2
Order By: Relevance
“…Finally, adaptations of our diagnostic method, such as allelic quantification by densitometry to detect carriers, and the use of DNA from amniotic fluid or chorionic villus for prenatal diagnosis [Phillips et al, 1989], would allow the establishment of genetic counseling in affected families and would also contribute valuable information for clinical specialists and to orient them in their therapeutic strategies. Fig.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Finally, adaptations of our diagnostic method, such as allelic quantification by densitometry to detect carriers, and the use of DNA from amniotic fluid or chorionic villus for prenatal diagnosis [Phillips et al, 1989], would allow the establishment of genetic counseling in affected families and would also contribute valuable information for clinical specialists and to orient them in their therapeutic strategies. Fig.…”
Section: Discussionmentioning
confidence: 99%
“…Initially, screening for hGH-N gene deletions was done by Southern blot [Phillips et al, 1989]. However, with the advent of the polymerase chain reaction (PCR), simpler alternative approaches were pursued to facilitate the detection of subjects with IGHD type IA [Vnencak-Jones et al, 1990]; while none have been reported for IPLD type IA.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Skirtingų literatūros šaltinių duomenimis, izoliuoto hipopituitarizmo (arba izoliuoto augimo hormono deficito) paplitimas vertinamas nuo 1:4000 iki 1:10 000 gyvagimių dėl hipofizės gaminamo augimo hormono arba jo geno patologijos ir sąlygoja augimo sutrikimą (1)(2)(3)(4). Dauginis hipopituitarizmas (DHP) pasitaiko rečiau -1:8000 gyvagimių arba dar rečiau (5-7), bet jo klinikiniai simptomai yra ryškesni: tokiems pacientams kartu su augimo sutrikimu randama centrinė hipotirozė, hipogonadotropinis hipogonadizmas, gali išryš-kėti ir antrinis antinksčių nepakankamumas.…”
Section: Genetiškai Determinuotas Hipopituitarizmasunclassified
“…Turintys šią mutaciją vaikai gimimo metu būna normalaus svorio ir ūgio, nesiskiria nuo kitų sveikų naujagimių. Perinatalinis laikotarpis dažniausiai sklandus, hipoglikemija gali būti lengva ir išlikti nepastebėta, arba jos visiškai nebūna (1). Hormonų trūkumo pasireiškimo pradžia labai skirtinga: jų stygius gali išryškėti jau vaikystėje arba išlikti nepastebėtas iki paauglystės.…”
Section: Genetiškai Determinuotas Hipopituitarizmasunclassified